drugset / Trial / NCT00421590
Drug Interaction of SMC021 With Concomitant Antacid (Calcium Carbonate/Magnesium Hydroxide).
RandomizedCrossoverDouble-blindTreatment
Summary
This study will assess the effect of concomitant antacid on the pharmacokinetics and pharmacodynamics of SMC021
Timeline
- Start
- 2006-10
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | salmon calcitonin | Unknown | 0.8 mg | Oral |
Indications
No indication recorded.